Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-...
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Columbia Data Analytics, LLC
2023-12-01
|
| coleção: | Journal of Health Economics and Outcomes Research |
| Acesso em linha: | https://doi.org/10.36469/001c.89300 |